Sofinnova Partners invests across the entire value chain of life sciences investments, from seed to later-stage. Our focus is on healthcare and sustainability. We proactively source deals, take a lead role, and are often the first institutional investor in Round A financings. We sit on the Boards of our portfolio companies and actively take part from creation to exit alongside our entrepreneurs. Sofinnova invests throughout Europe from our offices in Paris, London and Milan, with a portion of our investments made in the rest of the world.
We focus on three domains:
We invest in transformative innovations that have the potential to positively impact our collective future. Priority is given to projects with strong intellectual property and those that combine entrepreneurial track-record with pharmaceutical or industrial experience.
We invest in start-ups, typically originating in the academic world, as well as spin-offs, which are new companies formed around later stage assets that had been developed in larger corporations. This is particularly true in the field of biopharmaceuticals where we have generated a unique spin-off track record.